Antimicrobial peptides (AMPs), ancient molecules in the innate immune response of eukaryotes, have recently emerged as a promising new group to be evaluated in therapeutic intervention of infectious diseases (reviewed in Zasloff 2002). The gene discussed is ADSL; the disease is infectious disease.